The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like San Diego's Mirati Therapeutics Abandons Lead Drug, Shifts Focus November 14, 2017 <b>Saintyco</b> Introduces Portable Mini Fluid Bed Granulator And Coater For Labs & R&D June 5, 2017 Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest November 29, 2017
